Metabolic Acidosis

Pathophysiology and Core Concepts of Metabolic Acidosis

  • Metabolic acidosis is a physiological state characterized by an elevated concentration of hydrogen ions (H+\text{H}^+) in the serum and a corresponding decrease in serum bicarbonate (HCO3\text{HCO}_3).

  • Acid-base balance is determined by the concentration of hydrogen ions in the blood. When the serum hydrogen ion concentration increases, it results in acidosis, and the pHpH falls below 7.357.35.

  • Metabolic acidosis specifically involves a pHpH level below 7.357.35 coupled with a decreased serum bicarbonate level.

  • Several factors influence hydrogen ion concentration, including:

    • Renal bicarbonate loss.

    • Gastrointestinal bicarbonate loss.

    • Acid ingestion.

    • Alterations in acid production.

    • Alterations in acid excretion.

  • Bicarbonate acts as a critical buffer within the body to prevent significant alterations in pHpH levels.

  • The pHpH scale is a measurement used to determine the acidity or alkalinity of a substance.

  • Extracellular pHpH values within the normal range of 7.357.35 to 7.457.45 are essential for effective body function. Acid-base disorders occur when values fall outside this range.

  • Ventilation status in a patient is reflected by the partial pressure of carbon dioxide, while oxygenation status is reflected by the partial pressure of oxygen.

Etiology, Epidemiology, and Mechanisms

  • There are four primary underlying mechanisms responsible for the development of metabolic acidosis:

    1. Enhanced production of acid.

    2. Inhibited renal excretion of acid.

    3. Ingestion of exogenous acids, such as certain medications or drugs.

    4. Loss of bicarbonate via the renal system or the gastrointestinal system (e.g., through vomiting).

  • Specific causes and risk factors associated with metabolic acidosis include:

    • Salicylates (such as aspirin and nonsteroidal anti-inflammatory drugs).

    • Diabetic ketoacidosis (DKA).

    • BKA.

    • Uremia.

    • Kidney disease.

    • Iron.

    • Metformin.

    • Methanol (a toxic solvent).

    • Carbon monoxide poisoning.

    • Cyanide exposure.

    • Liver failure.

  • Metabolic acidosis is not categorized as an independent disease process; rather, it occurs as a result of an underlying pathology.

  • Epidemiology indicates this alteration is most common in acutely ill clients. Those with chronic kidney disease (CKD) are at particularly high risk due to the disease's inherent risk factors and trends.

Clinical Presentation and Manifestations

  • The clinical manifestations of metabolic acidosis vary depending on the underlying cause of the imbalance.

  • Kussmaul respirations are a distinct clinical sign where the respiratory center in the brain is stimulated by acidosis. These respirations follow a specific pattern:

    • They are initially fast and shallow.

    • They progressively become deeper.

  • Clients with diabetic ketoacidosis (DKA) may present with dry mucous membranes.

  • Hyperventilation often occurs as a compensatory mechanism to counter the acidemic state.

  • Additional manifestations, particularly if the imbalance is severe, include:

    • Nausea and vomiting.

    • Hemodynamic instability.

    • Confusion or lethargy.

    • Hypotension.

    • Dysrhythmias.

    • Shock.

Impact on Health and Aging Considerations

  • The prognosis for clients is strictly dependent on the underlying cause. If a client is unstable and experiencing significant metabolic acidosis, the prognosis is poor.

  • Potential complications of the disorder include:

    • Osteoporosis.

    • Worsening of existing kidney disease.

    • Shock.

    • Death.

  • Aging adult considerations:

    • Individuals aged 6565 years and older are more susceptible to metabolic acidosis because they may have decreased kidney function, making them less able to excrete acid from the body.

  • Health promotion and disease prevention:

    • Dietary adjustments can help prevent or decrease mild and chronic versions of the disorder.

    • Recommendations include consuming bicarbonate mineral waters and eating fruits and vegetables.

    • Effective management and prevention of primary conditions like DKA and kidney disease directly reduce the incidence of metabolic acidosis.

Arterial Blood Gas (ABG) Analysis and Diagnostics

  • Evaluation for metabolic acidosis involves an arterial blood gas (ABG) analysis as the primary diagnostic tool.

  • Other lab tests that may be obtained include:

    • Basic Metabolic Panel (BMP).

    • Urinalysis.

    • Complete Blood Count (CBC).

    • Venous and arterial blood gases.

    • Serum lactic acid.

  • ABG samples are obtained from an arterial source, such as the radial artery.

  • Core components of an ABG and their normal acceptable values include:

    • PHPH (Acid-base balance of blood): 7.357.35 to 7.457.45.

    • POW2POW_2 (Partial pressure of oxygen in arterial blood): 8080 to 100 mmHg100\,\text{mmHg}.

    • HOCO2HOCO_2 (Partial pressure of carbon dioxide in arterial blood): 3535 to 45 mmHg45\,\text{mmHg}.

    • HCO3HCO_3 (Concentration of bicarbonate in arterial blood): 2121 to 28 mEq/L28\,\text{mEq/L}.

    • Base excess/deficit (Excess or deficit of base in arterial blood): 0±2 mEq/L0 \pm 2\,\text{mEq/L}.

    • SA2SA_2 or SAW2SAW_2 (Arterial oxygen saturation): 95%95\% to 100%100\%.

Steps for Systematic ABG Interpretation

  • Step 1: Determine if the pHpH reflects acidosis or alkalosis. The pHpH usually indicates the underlying disorder, though acidosis or alkalosis can be present even if the pHpH falls within the acceptable range.

  • Step 2: Determine if the imbalance is respiratory or metabolic based on the direction of changes between pHpH and psiO2psiO_2:

    • Respiratory: pHpH and psiO2psiO_2 move in opposite directions.

    • Metabolic: pHpH and psiO2psiO_2 move in the same direction.

  • Step 3: Analyze the relationship between pHpH, HCO3HCO_3, and psiO2psiO_2 to determine compensation:

    • Metabolic Acidosis:

      • Partially Compensated: The pasio2pasio_2 is below the acceptable range and the pHpH is not within normal range.

      • Compensated: The pasio2pasio_2 is below the acceptable range and the pHpH is within the acceptable range.

    • Respiratory Acidosis:

      • Partially Compensated: The pHpH is outside the acceptable range and the HCO3HCO_3 is elevated above the acceptable range.

      • Compensated: The pHpH is within the normal range and the HCO3HCO_3 is elevated above the acceptable range.

    • Respiratory Alkalosis:

      • Uncompensated/Occurring: The pHpH is outside the acceptable range and the HCO3HCO_3 is below the acceptable range.

      • Compensated: The pHpH is within the acceptable range and the HCO3HCO_3 is below the acceptable range.

    • Metabolic Alkalosis:

      • Partially Compensated: The passe o2passe\,o_2 is elevated above the acceptable range and the pHpH is outside the normal range.

      • Compensated: The passe o2passe\,o_2 is elevated above the acceptable range and the pHpH is within the acceptable range.

Nursing Process and Clinical Management

  • Recognize Cues (Assessment):

    • Collect data from health history, including incidents of vomiting, medication use, or exposure to toxic substances.

    • Assess for Kussmaul respirations, dry mucous membranes, confusion, hyperventilation, dysrhythmias, hypotension, and shock.

  • Analyze Cues (Analysis) and Prioritize Hypotheses:

    • Review history to identify needs related to respiratory alterations or gastrointestinal issues.

    • Priority needs include cardiovascular alterations such as dysrhythmias and hypotension, as these are life-threatening.

  • Take Action (Implementation):

    • Initiate and maintain intravenous (IV) fluids.

    • Monitor intake and output (I&O).

    • Administer oxygen if indicated.

    • Monitor cardiac activity.

    • Administer medications such as insulin (for DKA) and sodium bicarbonate.

    • Regularly monitor laboratory results, including ABGs, toxin levels, and electrolytes.

  • Evaluate Outcomes:

    • Effectiveness is marked by the resolution of clinical manifestations like hyperventilation and confusion, and the normalization of serum pHpH.

Treatments and Alkalinization Therapy

  • The primary focus of treatment is correcting the underlying cause of the imbalance.

  • Mild to Moderate Cases: IV fluids and respiratory support are generally sufficient for correction.

  • Severe Acidosis (pH<7.1pH < 7.1):

    • Strategy: Alkalinization therapy.

    • Drug of Choice: Sodium bicarbonate is used to alkalinize the serum and urine.

    • Mechanism: It increases serum bicarbonate levels to buffer hydrogen ions, increasing serum pHpH, and enhances the renal excretion of acidic substances.

    • Administration: Can be given intravenously or orally (via tablets or citrate salts).

  • Diabetic Ketoacidosis (DKA) Management:

    • Clients often present with a pHpH level below 6.96.9.

    • Treatment requires administration of insulin and fluids to correct electrolyte disturbances.

  • Dialysis: This may be utilized for the removal of certain drugs or toxic substances from the blood.